These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy. Deayton JR; Prof Sabin CA; Johnson MA; Emery VC; Wilson P; Griffiths PD Lancet; 2004 Jun; 363(9427):2116-21. PubMed ID: 15220032 [TBL] [Abstract][Full Text] [Related]
3. Clinical significance of qualitative human cytomegalovirus (HCMV) detection in cell-free serum samples in HIV-infected patients at risk for HCMV disease. Laue T; Mertenskötter T; Grewing T; Degen O; van Lunzen J; Dietrich M; Schmitz H AIDS; 1997 Jul; 11(9):1195-6. PubMed ID: 9233475 [No Abstract] [Full Text] [Related]
4. Sharp drop in the prevalence of human cytomegalovirus leuko-DNAemia in HIV-infected patients following highly active antiretroviral therapy. Gerna G; d'Arminio Monforte A; Zavattoni M; Sarasini A; Testa L; Revello MG; Moroni M AIDS; 1998 Jan; 12(1):118-20. PubMed ID: 9456267 [No Abstract] [Full Text] [Related]
5. Clinical relevance of cytomegalovirus viraemia(*,†). El Amari EB; Combescure C; Yerly S; Calmy A; Kaiser L; Hasse B; Furrer H; Cavassini M; Vernazza P; Hirsch H; Bernasconi E; Hirschel B; HIV Med; 2011 Aug; 12(7):394-402. PubMed ID: 21251182 [TBL] [Abstract][Full Text] [Related]
6. Lessons learned from HIV pathogenesis and therapy: implications for better management of cytomegalovirus disease. Hardy WD AIDS; 1996 Nov; 10 Suppl 1():S31-5. PubMed ID: 8970674 [TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus viraemia in the modern antiretroviral era(*). Jacobson M; Lurain N; Hunt P HIV Med; 2011 Aug; 12(7):387-8. PubMed ID: 21729228 [No Abstract] [Full Text] [Related]
8. Human cytomegalovirus (HCMV)-specific CD4+ T lymphocyte response in AIDS patients with no past or current HCMV disease following HAART. Tamarit A; Alberola J; Mir A; Benet I; Mira JV; Muñoz C; Galindo MJ; Navarro D J Clin Virol; 2004 Apr; 29(4):308-14. PubMed ID: 15018860 [TBL] [Abstract][Full Text] [Related]
9. Quantitation of cytomegalovirus (CMV) DNA in leukocytes of human immunodeficiency virus-infected subjects with and without CMV disease by using PCR and the SHARP Signal Detection System. Boivin G; Handfield J; Murray G; Toma E; Lalonde R; Lazar JG; Bergeron MG J Clin Microbiol; 1997 Feb; 35(2):525-6. PubMed ID: 9003635 [TBL] [Abstract][Full Text] [Related]
10. Emergence of multiple drug-resistant human cytomegalovirus variants in 2 patients with human immunodeficiency virus infection unresponsive to highly active antiretroviral therapy. Baldanti F; Paolucci S; Parisi A; Meroni L; Gerna G Clin Infect Dis; 2002 Apr; 34(8):1146-9. PubMed ID: 11915006 [TBL] [Abstract][Full Text] [Related]
11. Human cytomegalovirus infection among patients living with AIDS in a tertiary level hospital in India. Chakravarti A; Tewari S; Bhalla P J Int Assoc Physicians AIDS Care (Chic); 2010; 9(2):94-7. PubMed ID: 20484735 [TBL] [Abstract][Full Text] [Related]
12. Impact of detectable human cytomegalovirus DNAemia on viro-immunological effectiveness of HAART in HIV-infected patients naive to antiretroviral therapy. Focà E; Motta D; Pollara C; Brianese N; Gotti D; Albini L; Quiros-Roldan E; Torti C; Manca N New Microbiol; 2012 Apr; 35(2):227-31. PubMed ID: 22707137 [TBL] [Abstract][Full Text] [Related]
14. Expression of the late cytomegalovirus (CMV) pp150 transcript in leukocytes of AIDS patients is associated with a high viral DNA load in leukocytes and presence of CMV DNA in plasma. Boivin G; Handfield J; Toma E; Lalonde R; Bergeron MG J Infect Dis; 1999 May; 179(5):1101-7. PubMed ID: 10191210 [TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus disease in the era of highly active antiretroviral therapy (HAART). Steininger C; Puchhammer-Stöckl E; Popow-Kraupp T J Clin Virol; 2006 Sep; 37(1):1-9. PubMed ID: 16675299 [TBL] [Abstract][Full Text] [Related]
16. Quantitation of cytomegalovirus (CMV) DNA by real-time PCR for occurrence of CMV disease in HIV-infected patients receiving highly active antiretroviral therapy. Gourlain K; Salmon D; Gault E; Leport C; Katlama C; Matheron S; Costagliola D; Mazeron MC; Fillet AM; ; J Med Virol; 2003 Mar; 69(3):401-7. PubMed ID: 12526052 [TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus viraemia in HIV exposed and infected infants: prevalence and clinical utility for diagnosing CMV pneumonia. Hsiao NY; Zampoli M; Morrow B; Zar HJ; Hardie D J Clin Virol; 2013 Sep; 58(1):74-8. PubMed ID: 23727304 [TBL] [Abstract][Full Text] [Related]
18. Level of cytomegalovirus (CMV) DNA in cerebrospinal fluid of subjects with AIDS and CMV infection of the central nervous system. Arribas JR; Clifford DB; Fichtenbaum CJ; Commins DL; Powderly WG; Storch GA J Infect Dis; 1995 Aug; 172(2):527-31. PubMed ID: 7622897 [TBL] [Abstract][Full Text] [Related]
19. Detection of lymphotropic herpesvirus DNA by polymerase chain reaction in cerebrospinal fluid of AIDS patients with neurological disease. Broccolo F; Iuliano R; Careddu AM; Trovato R; Lico S; Blanc PL; Mazzotta F; Ceccherini-Nelli L Acta Virol; 2000; 44(3):137-43. PubMed ID: 11155355 [TBL] [Abstract][Full Text] [Related]
20. Impact of highly active antiretroviral therapy on cytomegalovirus viraemia in the absence of specific anti-cytomegalovirus therapy. Mihăilescu R; Arama V; Paraschiv S; Streinu-Cercel A; Oţelea D; Munteanu D; Iosipenco M; Chiotan C; Benea OE; Mărdărescu M; Rădulescu M; Hristea A; Ungurianu R; Aramă SS; Cercel AS; Călin R; Băicuş C Rom J Intern Med; 2008; 46(4):305-11. PubMed ID: 19480296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]